Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

UPDATE 1-WHO to decide whether worst over in H1N1 pandemic

Published 02/11/2010, 07:44 AM
Updated 02/11/2010, 07:48 AM

* WHO committee to decide if H1N1 has peaked

* Meets later this month

* Recommendations for next seasonal flu jab on Feb. 18

(Adds quotes, background, details, seasonal flu)

GENEVA, Feb 11 (Reuters) - The World Health Organisation will convene its emergency committee later this month to examine whether the H1N1 flu pandemic has peaked, its top influenza expert said on Thursday.

"What we are hoping for is that the worst is behind us," Keiji Fukuda told a news conference.

Fukuda said the committee, which makes recommendations on the state of a pandemic to WHO Director-General Margaret Chan, would decide whether the H1N1 pandemic declared in June had entered a post-peak or transition phase.

Designating a transition phase in this way -- indicating that the pandemic is continuing but the overall trend is back towards seasonal patterns of influenza -- would help national health authorities look to the future, he said.

Even if the WHO decided the pandemic had peaked, the virus remained active, causing disease and death, and could continue to flare up in some regions, as it had done recently in West Africa, Fukuda said

"The ending of a pandemic cannot be construed an abrupt on-or-off situation," he said.

Laboratory-confirmed deaths total more than 15,000, but the real toll is likely to be much higher, although that will not be established for a year or two, he said.

The WHO has not yet set a firm date for the emergency committee meeting, but it would probably be in the last week of February, Fukuda said.

Another group of influenza experts will meet next week to make recommendations on the composition of the flu vaccine for the next northern hemisphere influenza season, he said.

The recommendations will be published on Feb. 18.

Fukuda noted that H1N1 remained the most dominant influenza virus, so it was possible that it would be included in the next seasonal jab. (Additional reporting by Kate Kelland in London) (Reporting by Jonathan Lynn; Editing by Stephanie Nebehay)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.